A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998

Clinical Therapeutics

Volumn 25, Issue 5, 2003, Pages 1503-1517

  Ma, Jun ^a   Stafford, Randall S ^a   Cockburn, Iain M ^b   Finkelstein, Stan N ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Direct to consumer advertising; Office promotion; Pharmaceutical promotion

Indexed keywords

ANTACID AGENT; ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; CONTRACEPTIVE AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; URINARY TRACT AGENT;

ADVERTIZING; ARTICLE; BIOAVAILABILITY; CLUSTER ANALYSIS; CONCENTRATION RESPONSE; CONSUMER; DRUG COST; DRUG INDUSTRY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PHYSICIAN; SAMPLING; SMOKING CESSATION; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0038282734     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)80136-4     Document Type: Article

References (19)

1. National Institute for Health Care Management Research and Educational Foundation. Prescription Drug Expenditures in 2001: Another Year of Escalating Costs. Washington, DC: National Institute for Health Care Management Research and Educational Foundation; 2002.
2. Carrin G. Drug prescribing: A discussion of its variability and (ir)rationality. Health Policy. 1987;7:73-94.
3. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997;277:312-317.
4. Levy R. The role and value of pharmaceutical marketing. Arch Fam Med. 1994;3:327-332.
5. Leffler KB. Persuasion or information? The economics of prescription drugs advertising. J Law Econ. 1981;24:45-74.
6. Mackowiak JI, Gagnon JP. Effects of promotion on pharmaceutical demand. Soc Sci Med. 1985;20:1191-1197.
7. Rosenthal MB, Berndt ER, Donohue JM, et al. Promotion of prescription drugs to consumers. N Engl J Med. 2002;346:498-505.
8. National Institute for Health Care Management Research and Educational Foundation. Prescription Drugs and Mass Media Advertising, 2000. Washington, DC: National Institute for Health Care Management Research and Educational Foundation; 2001.
9. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Aff (Millwood). 2000;19:110-128.
10. Chew LD, O'Young TS, Hazlet TK, et al. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 2000;15:478-483.
11. Goodman B. Do drug company promotions influence physician behavior? West J Med. 2001;174:232-233.
12. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8.
13. Wagstaff A. Inequality aversion, health inequalities and health achievement. J Health Econ. 2002;21:627-641.
14. Lee WC. Characterizing exposure-disease association in human populations using the Lorenz curve and Gini index. Stat Med. 1997;16:729-739.
15. Hair JF, Tatham RL, Anderson RE, Black WC. Cluster analysis. In: Multivariate Data Analysis. 5th ed. Upper Saddle River, NJ: Prentice Hall; 1998:469-518.
16. Heffler S, Levit K, Smith S, et al. Health spending growth up in 1999; faster growth expected in the future. Health Aff (Millwood). 2001;20:193-203.
17. Hurwitz MA, Caves RE. Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. J Law Econ. 1988;31:299-320.
18. Stern S, Trajtenberg M. Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking. Cambridge, Mass: Massachusetts Institute of Technology Program on the Pharmaceutical Industry; 1998. Working Paper 45-98.
19. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA. 2002;288:1260-1264.